1-1 of 1
Istvan Matyas Majer, PhD
Close
Sort by
Journal Articles

Economic Evaluation of Carfilzomib+Dexamethasone (Kd) Vs Bortezomib+Dexamethasone (Vd) in Relapsed or Refractory Multiple Myeloma (R/RMM)

Andrzej Jakubowiak, MD PhD, Istvan Matyas Majer, PhD, Ivan Houisse, MSc, Agnes Benedict, Marco Campioni, Sumeet Panjabi, Sikander Ailawadhi, MD
Journal: Blood
Blood (2016) 128 (22): 3582.
https://doi.org/10.1182/blood.V128.22.3582.3582
Published: 2016